Exploring the components of the human virome across Canadian adults
Summary
The purpose of this study is to better understand the role of viruses in the human microbiome and how they impact our health. This study aims to better understand the viruses and bacteria that live in and on our bodies, specifically focusing on the gut, mouth, and vagina. These tiny organisms play a crucial role in our health, and by studying them, we aim to uncover new insights that could lead to better health outcomes in the future. Participants will be asked to provide fecal, saliva, and vaginal swab samples and to complete questionnaires about their health and background information. The study will take around 2.5 hours of time, with 2 hours required in person.
Using the samples, the project aims (1) to isolate and study important human viruses, (2) to improve techniques for detecting viruses in samples, (3) to identify which viruses are targeted by our immune system, and (4) to investigate how certain human genetic elements interact with the virome.
Eligibility
Eligible ages: 19 to 100
Accepts healthy participants: Yes
Inclusion criteria:
1) 19+ years old
2) Able to communicate in English
3) Generally healthy and able to complete the study questionnaires/assessments
Exclusion criteria:
1) Non-correctable vision or hearing impairment
2) HIV+, HCV+, HBV+
3) Mental or physical illness preventing participating in study activities
4) Currently pregnant
5) Currently have a severe illness or and/or are addicted to narcotics
5) Unable to communicate in English
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Please contact Dr. Ann Gregory at ann.gregory@ucalgary.ca for information about how to participate in the study.
Principal investigator:
Ann Gregory
Clinical trial:
No
REB-ID:
REB24-0298